Research
Interests
Current
Projects
Selected Recent Publications
Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
Barrachina M, Castano E, Dalfo E, Maes T, Buesa C, Ferrer I.
Neurobiol Dis. 2005 Dec 24; [Epub ahead of print]
Abnormal Sp1 transcription factor expression in Alzheimer disease and
tauopathies.
Santpere G, Nieto M, Puig B, Ferrer I.
Neurosci Lett. 2005 Dec 22; [Epub ahead of print]
Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease.
Freixes M, Rodriguez A, Dalfo E, Ferrer I.
Neurobiol Aging. 2005 Nov 23; [Epub ahead of print]
Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I, Barrachina M, Puig B, Martinez de Lagran M, Marti E, Avila J,Dierssen M.
Neurobiol Dis. 2005 Nov;20(2):392-400.
Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage.
Ferrer I, Kapfhammer JP, Hindelang C, Kemp S, Troffer-Charlier N, Broccoli V, Callyzot N, Mooyer P, Selhorst J, Vreken P, Wanders RJ, Mandel JL, Pujol A.
Hum Mol Genet. 2005 Dec 1;14(23):3565-77. Epub 2005 Oct 13.
Evidence of oxidative stress in the neocortex in incidental Lewy body disease.
J Neuropathol Exp Neurol. 2005 Sep;64(9):816-30.
Dalfo E, Portero-Otin M, Ayala V, Martinez A, Pamplona R,Ferrer I.
Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
Ribe EM, Perez M, Puig B, Gich I, Lim F, Cuadrado M, Sesma T, Catena S, Sanchez B, Nieto M, Gomez-Ramos P, Moran MA, Cabodevilla F, Samaranch L, Ortiz L, Perez A, Ferrer I, Avila J, Gomez-Isla T.
Neurobiol Dis. 2005 Dec;20(3):814-22. Epub 2005 Aug 24.
Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T, Tolosa E, Ferrer I.
Mov Disord. 2005 Aug;20 Suppl 12:S21-8.
[Congenital insensitivity to pain with anhidrosis associated with congenital myasthenic syndrome]
Raspall-Chaure M, Del Toro-Riera M, Gratacos M, Cuenca-Leon E, Ferrer I,Indo Y, Roig-Quilis M, Macaya-Ruiz A.
Rev Neurol. 2005 Aug 16-31;41(4):218-22. Spanish.
Abnormal group I metabotropic glutamate receptor expression and signaling in the frontal cortex in Pick disease.
Dalfo E, Albasanz JL, Rodriguez A, Martin M, Ferrer I.
J Neuropathol Exp Neurol. 2005 Jul;64(7):638-47.
Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
Brell M, Tortosa A, Verger E, Gil JM, Vinolas N, Villa S, Acebes JJ, Caral L, Pujol T, Ferrer I, Ribalta T, Graus F.
Clin Cancer Res. 2005 Jul 15;11(14):5167-74.
BetaII-tubulin and phospho-tau aggregates in Alzheimer's disease and Pick's disease.
Puig B, Ferrer I, Luduena RF, Avila J.
J Alzheimers Dis. 2005 Jun;7(3):213-20; discussion 255-62.
Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice.
Nieto M, Gil-Bea FJ, Dalfo E, Cuadrado M, Cabodevilla F, Sanchez B, Catena S, Sesma T, Ribe E, Ferrer I, Ramirez MJ, Gomez-Isla T.
Neurobiol Aging. 2005 Jul 7; [Epub ahead of print]
Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribe E, Dalfo E, Avila J.
Curr Alzheimer Res. 2005 Jan;2(1):3-18. Review.
Individual and regional variations of phospho-tau species in progressive supranuclear palsy.
Puig B, Rey MJ, Ferrer I.
Acta Neuropathol (Berl). 2005 Sep;110(3):261-8. Epub 2005 Jun 23.
Neuronal intranuclear inclusion disease in a horse.: 15971054
Pumarola M, Vidal E, Trens JM, Serafin A, Marquez M, Ferrer I.
Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
Albasanz JL, Dalfo E, Ferrer I, Martin M.
Neurobiol Dis. 2005 Dec;20(3):685-93. Epub 2005 Jun 8.
Myotilinopathy: refining the clinical and myopathological phenotype.
Olive M, Goldfarb LG, Shatunov A, Fischer D, Ferrer I.
Brain. 2005 Oct;128(Pt 10):2315-26. Epub 2005 Jun 9.
Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis.
Ferrer I, Carmona M, Blanco R, Moreno D, Torrejon-Escribano B, Olive M.
Brain Pathol. 2005 Apr;15(2):101-8.
Spinocerebellar ataxia type 2 (SCA2) with white matter involvement.
Armstrong J, Bonaventura I, Rojo A, Gonzalez G, Corral J, Nadal N, Volpini V, Ferrer I.
Neurosci Lett. 2005 Jun 24;381(3):247-51. Epub 2005 Mar 17.
Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
Ibernon M, Gil-Vernet S, Carrera M, Seron D, Moreso F, Bestard O, Cruzado JM, Grinyo JM.
Transplant Proc. 2005 Nov;37(9):3743-5.
Glomerular size in early protocol biopsies is associated with graft outcome.
Azevedo F, Alperovich G, Moreso F, Ibernon M, Goma M, Fulladosa X, Hueso M, Carrera M, Grinyo JM, Seron D.
Am J Transplant. 2005 Dec;5(12):2877-82.
Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome.
Vallejos A, Alperovich G, Moreso F, Canas C, de Lama ME, Goma M,
Fulladosa X, Carrera M, Hueso M, Grinyo JM, Seron D.
Nephrol Dial Transplant. 2005 Nov;20(11):2511-6. Epub 2005 Aug 2.
Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial.
Mengel M, Bogers J, Bosmans JL, Seron D, Moreso F, Carrera M, Gwinner W,Schwarz A, De Broe M, Kreipe H, Haller H; ESPRIT group.
Am J Transplant. 2005 May;5(5):1050-6.
Evaluation of pre-implantation kidney biopsies: comparison of Banff criteria to a morphometric approach.
Lopes JA, Moreso F, Riera L, Carrera M, Ibernon M, Fulladosa X, Grinyo JM,Seron D.
Kidney Int. 2005 Apr;67(4):1595-600.
Tissue imprints or primary cultures: which strategy to use to study cytogenetic clonality?
Nadal M, Pera G, Gomez-Zaera M, Abril J, Suarez JF, Aguilo F, Condom E, Nunes V.
Diagn Mol Pathol. 2005 Dec;14(4):243-6.
Subperiosteal leiomyosarcoma of the tibia.
Narvaez JA, De Lama E, Portabella F, Ortega R, Condom E.
Skeletal Radiol. 2005 Jan;34(1):42-6. Epub 2004 Oct 2.
KCNQ1/KCNE1 channels during germ-cell differentiation in the rat: expression associated with testis pathologies.
Tsevi I, Vicente R, Grande M, Lopez-Iglesias C, Figueras A, Capella G,Condom E, Felipe A.
J Cell Physiol. 2005 Feb;202(2):400-10.
Pluvinet R,Lloberas N, Rama I, Cruzado JM, Gulias O, Grinyo JM.
Role of cold ischemia in acute rejection: characterization of a humoral-like
Herrero-Fresneda I, Franquesa M, Torras J, Vidal A, Aran J,
A novel logistic model based on clinicopathological features predicts
microsatellite instability in colorectal carcinomas.
Colomer A, Erill N, Vidal A, Calvo M, Roman R, Verdu M, Cordon-Cardo C, Puig X.
Diagn Mol Pathol. 2005 Dec;14(4):213-23.
Cellulitis caused by Cryptococcus neoformans in a lung transplant recipient.
Rakvit A, Meyerrose G, Vidal AM, Kimbrough RC, Sarria JC.
J Heart Lung Transplant. 2005 May;24(5):642. No abstract available.
Reduction of postischemic immune inflammatory response: an effective strategy for attenuating chronic allograft nephropathy.
Herrero-Fresneda I, Torras J, Vidal A, Lloberas N, Cruzado JM, Grinyo JM.
Transplantation. 2005 Jan 27;79(2):165-73.
[Obstructive jaundice secondary to lymphoplasmocitic cholangitis. Differential diagnosis of Klastkin tumors.]
Utrillas AC, Llado L, Alba E, Valls C, Cruz M, Figueras J, Serrano T, Ramos E, Torras J, Rafecas A.
Rev Esp Enferm Dig. 2005 Dec;97(12):923-4. Spanish. No abstract available.
Clinical and virological effects during two years of ongoing adefovir dipivoxil in the treatment of lamivudine-resistant chronic hepatitis B infection.
Gornals JB, Casanovas T, Sabido M, Baliellas C, Casanovas A, Canas C, Serrano T, Verdura B, Chahri N, Gil-Vernet S, Figueras J.
Transplant Proc. 2005 Nov;37(9):3957-9.
The histologic pattern of "biliary tract pathology" in postoperative biopsies and the study of postperfusion biopsy are accurate for the diagnosis of biliary complications.
Busquets J, Serrano T, Torras J, Figueras J.
Am J Surg Pathol. 2005 Dec;29(12):1684; author reply 1684. No abstract
available.
Biliary complications after liver transplantation: diagnosis with MR
cholangiopancreatography.
Valls C, Alba E, Cruz M, Figueras J, Andia E, Sanchez A, Llado L, Serrano T.
AJR Am J Roentgenol. 2005 Mar;184(3):812-20.